Home|Journals|Articles by Year|Audio Abstracts
 

Review Article



Phage therapy: An old concept with new perspectives

Izabela Durbas, Grzegorz Machnik.




Abstract
Cited by 2 Articles

The ever-increasing bacterial resistance to antibiotics and the growing number of severe, hard-to-treat infections have driven international studies into a race to develop alternative, less conventional methods of treatment. One such antibacterial strategy has been around for a relatively long time, just recently resparking scientific interest: it is called phage therapy. In the fight against multidrug-resistant bacterial infections, this method employs one of the most abundant organisms on the planet Earth—bacteriophages—a type of intriguing, spiderlike viruses which infect bacteria. The newest research in the field of phage therapy and its applications in medicine suggests that this method indeed has the potential to become an alternative form of treatment for patients suffering from various diseases, as it turns out, not only bacterial infections. However, there is still much to be learnt about phage biology, its impact on the human body, and its interactions with bacteria. Nonetheless, in the face of a significant global health threat, the time has come to reexamine this almost-century-old medical strategy.

Key words: Bacteriophages, Phage Therapy, Drug Resistance, Anti-Bacterial Agents, Bacterial Infections






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.